3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Nasopharyngeal Carcinoma
20
Prostatic Neoplasms
7
Breast Neoplasms
7
Head and Neck Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Esophageal Neoplasms
6
Rectal Neoplasms
4
Radiation Injuries
4
Carcinoma, Squamous Cell
4
Carcinoma, Non-Small-Cell Lung
4
Neoplasm Metastasis
3
Nasopharyngeal Neoplasms
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Salivary Gland Neoplasms
2
Recurrence
2
Lung Neoplasms
2
Vulvar Neoplasms
1
Thyroid Neoplasms
1
Sinonasal undifferentiated carcinoma
1
Radiation
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ototoxicity
1
Obesity
1
Neurotoxicity Syndromes
1
Neoplasms
1
Interventions
Cisplatin
2
tislelizumab
1
pembrolizumab
1
durvalumab
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Nivolumab
1
Niacinamide
1
Immunotherapy
1
Hyaluronic Acid
1
Esophagectomy
1
Drug Therapy
1
Cryotherapy
1
Cetuximab
1
Carboplatin
1
Brachytherapy
1
Aerosols
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Deglutition Disorders
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT05596890
2022-11-28
PICCRT
Guangdong Provincial People's Hospital
Phase 2
Unknown
50 enrolled